scholarly journals Design and Construction of pH-Selective Self-Lytic Liposome System

Processes ◽  
2020 ◽  
Vol 8 (12) ◽  
pp. 1526
Author(s):  
Ayumi Kashiwada ◽  
Kana Namiki ◽  
Haruka Mori

Liposomes are well-investigated drug or gene delivery vehicles for chemotherapy, used by taking advantage of their biocompatibility and biodegradability. A central question on the construction of intracellular liposomal delivery systems is to entrap the liposomes of interest in the highly acidic and proteolytic endosomal environment. In the other words, it is essential that the liposomes release a therapeutic drug into the cytosol before they are degraded in the endosome. As a strategy to enhance the endosome escape, the self-lytic liposomes with acidic pH-selective membrane active polypeptide are considered highly effective. Here, an acidic pH-selective membrane-lytic polypeptide (LPE) and its retro isomer (rLPE) were designed, and then their membrane-lytic activities against EggPC liposomes were determined. It was noticed that the rLPE polypeptide showed an increase in activity compared with the LPE polypeptide. Furthermore, the rLPE polypeptide was conjugated to liposomes via a flexible Gly-Gly-Gly-Gly linker to facilitate the pH-selective content release. The rLPE anchoring liposomes exhibited distinctly different contents release behavior at physiological and endosomal pHs, namely typical contents release from liposomes was positively observed at acidic pH range. The overarching goal of this paper is to develop efficient pH-selective therapeutic delivery systems by using our findings.

Author(s):  
P. V. KAMALA KUMARI ◽  
KETHA SRILEKHYA ◽  
K. BHAVYA SINDHU ◽  
Y. SRINIVASA RAO

Exosomes are the extracellular vesicles surrounded by a phospholipid bilayer shed from all cell varieties and plays a significant role in the communication and Transportation of materials between the cells due to their ability to transfer the proteins and nucleic acids from One cell to the another cell. Analogous in size and performance to synthetic nanoparticles, exosomes provide several Advantages, rendering them the foremost promising candidates for targeted drug or gene delivery vehicles. This review highlights the isolation techniques and delivery potential of exosomes, and equally presents research or analysis gaps for enhancing the use of natural vesicles for delivery functions. Exosome-based drug formulations can be applied to an extensive variety of diseases such as various infectious, cardiovascular, cancer and neurodegenerative disorders. Mostly, exosomes combine the benefits of both synthetic nanocarriers and cell-mediated drug delivery systems however avoiding their limitations.


2010 ◽  
Vol 75 (5) ◽  
pp. 563-575 ◽  
Author(s):  
Moslem Mohammadi ◽  
Mehdi Khodadadian ◽  
Mohammad K. Rofouei

A plasticized poly(vinyl chloride) membrane electrode based on 4-[(5-mercapto-1,3,4-thiadiazol-2-ylimino)methyl]benzene-1,3-diol (L) for highly selective determination of palladium(II) (in PdCl42– form) is developed. The electrode showed a good Nernstian response (29.6 ± 0.4 mV per decade) over a wide concentration range (3.1 × 10–7 to 1.0 × 10–2 mol l–1). The limit of detection was 1.5 × 10–7 mol l–1. The electrode has a response time of about 20 s, and it can be used for at least 2 months without observing any considerable deviation from Nernstian response. The proposed electrode could be used in the pH range of 2.5–5.5. The practical utility of the electrode has been demonstrated by its use for the estimation of palladium content in aqueous samples.


Author(s):  
Delly Ramadon ◽  
Maeliosa T. C. McCrudden ◽  
Aaron J. Courtenay ◽  
Ryan F. Donnelly

AbstractTransdermal drug delivery systems have become an intriguing research topic in pharmaceutical technology area and one of the most frequently developed pharmaceutical products in global market. The use of these systems can overcome associated drawbacks of other delivery routes, such as oral and parenteral. The authors will review current trends, and future applications of transdermal technologies, with specific focus on providing a comprehensive understanding of transdermal drug delivery systems and enhancement strategies. This article will initially discuss each transdermal enhancement method used in the development of first-generation transdermal products. These methods include drug/vehicle interactions, vesicles and particles, stratum corneum modification, energy-driven methods and stratum corneum bypassing techniques. Through suitable design and implementation of active stratum corneum bypassing methods, notably microneedle technology, transdermal delivery systems have been shown to deliver both low and high molecular weight drugs. Microneedle technology platforms have proven themselves to be more versatile than other transdermal systems with opportunities for intradermal delivery of drugs/biotherapeutics and therapeutic drug monitoring. These have shown that microneedles have been a prospective strategy for improving transdermal delivery systems. Graphical abstract


Membranes ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 504
Author(s):  
Sabry Khalil ◽  
Ashraf Y. Elnaggar

The study involves the fabrication of an aluminum liquid membrane sensor based on the association of aluminum ions with the cited reagent 2,9-dimethyl-4,11-diphenyl -1,5,8,12-tetraaza cyclote tradeca-1,4,8,11-tetraene [DDTCT]. The characteristics slope (58 mV), rapid and linear response for aluminum ion was displayed by the proposed sensor within the concentration range 2.5 × 10−7–1.5 × 10−1 M, the detection limit (1.6 × 10−7) M, the selectivity behavior toward some metal cations, the response time 10 s), lifetime (150 days), the effect of pH on the suggested electrode potential and the requisite analytical validations were examined. The suitable pH range was (5.0–8.0 ), in this range the proposed electrode response is independent of pH. The suggested electrode was applied to detect the aluminum ions concentration in food products, real samples and standard alloys. The resulting data by the suggested electrode were statistically analyzed, and compared with the previously reported aluminum ion-selective electrodes in the literature.


Life ◽  
2021 ◽  
Vol 11 (7) ◽  
pp. 682
Author(s):  
Andreea Crintea ◽  
Alina Gabriela Dutu ◽  
Gabriel Samasca ◽  
Ioan Alexandru Florian ◽  
Iulia Lupan ◽  
...  

Even though there are various types of cancer, this pathology as a whole is considered the principal cause of death worldwide. Lung cancer is known as a heterogeneous condition, and it is apparent that genome modification presents a significant role in the occurrence of this disorder. There are conventional procedures that can be utilized against diverse cancer types, such as chemotherapy or radiotherapy, but they are hampered by the numerous side effects. Owing to the many adverse events observed in these therapies, it is imperative to continuously develop new and improved strategies for managing individuals with cancer. Nanomedicine plays an important role in establishing new methods for detecting chromosomal rearrangements and mutations for targeted chemotherapeutics or the local delivery of drugs via different types of nano-particle carriers to the lungs or other organs or areas of interest. Because of the complex signaling pathways involved in developing different types of cancer, the need to discover new methods for prevention and detection is crucial in producing gene delivery materials that exhibit the desired roles. Scientists have confirmed that nanotechnology-based procedures are more effective than conventional chemotherapy or radiotherapy, with minor side effects. Several nanoparticles, nanomaterials, and nanosystems have been studied, including liposomes, dendrimers, polymers, micelles, inorganic nanoparticles, such as gold nanoparticles or carbon nanotubes, and even siRNA delivery systems. The cytotoxicity of such nanosystems is a debatable concern, and nanotechnology-based delivery systems must be improved to increase the bioavailability, biocompatibility, and safety profiles, since these nanosystems boast a remarkable potential in many biomedical applications, including anti-tumor activity or gene therapy. In this review, the nanosystems involved in treating lung cancer and its associated challenges are discussed.


2004 ◽  
Vol 55 (8) ◽  
pp. 635-640 ◽  
Author(s):  
Kenji Yoshino ◽  
Kentaro Sakai ◽  
Yoko Mizuha ◽  
Ayako Shimizuike ◽  
Shigeru Yamamoto

2017 ◽  
Vol 8 (7) ◽  
pp. 543-556 ◽  
Author(s):  
Hollie Hathaway ◽  
Scarlet Milo ◽  
J Mark Sutton ◽  
Toby A Jenkins

Author(s):  
Ameneh Mohammadi ◽  
Pooria Gill ◽  
Pedram Ebrahimnejad ◽  
Said Abediankenari ◽  
Zahra Kashi

: The application of nanotechnology in medicine and pharmaceutical purpose suggested a novel procedure in the nanotechnology terminology as nanomedicine. There is a wide range of applications for nanotechnology in medicine, such as the use of nanocarriers in drug delivery systems. Recently a remarkable attention to DNA has been made through its amazing functionality and its nature as a nanomaterial in biological systems. Since DNA is a biocompatible, the use of DNA as a nanomaterial in medicine has shown a great perspective of rational engineering of DNA nanostructures. According to new approaches in treatment of diseases in gene levels, gene therapy, using DNA as a nanomedicine possesses an important role in the medical sciences as the researchers published enormous papers and patents in the fields, for instance, the applications of DNA and DNA-based nanostructures as drug or gene nanocarriers, DNA-based diagnostics and DNA nanovasccines. Here, some examples of DNA-based nanomedicine in the patent frame were reviewed.


Sign in / Sign up

Export Citation Format

Share Document